Functional digestive disorders in children. Guidelines of the Society of Pediatric Gastroenterologists, Hepatologists and Nutritionists. Part 2

A group of experts, leading specialists in the field of pediatric gastroenterology have prepared clinical recommendations for the diagnosis and treatment of functional digestive disorders in children; they have summarized the international recommendations and domestic experience, suggesting the tactics of in everyday pediatrician’s practice. The second part of the guidelines discusses functional disorders with abdominal pain: functional nausea and vomiting, functional dyspepsia, irritable bowel syndrome, functional abdominal pain. The authors have clarified the definitions, classification and criteria for the diagnosis of functional dyspepsia and irritable bowel syndrome taking into account actual concepts. They also have defined current therapeutic principles. The diagnosis of functional nausea and vomiting, as well as functional abdominal pain, is rarely found in our pediatric practice, and therefore the detailed information provided on these diseases is of particular importance for a practitioner.

1. Pimanov S.I., Silivonchik N.N. Roman IV recommendations for the diagnosis and treatment of functional gastroenterological disorders. Manual for doctors. Moscow, 2016; 136—137. (in Russ.)

2. Hyams J.S., Di Lorenzo S., Saps M., Shulman R.J., Staiano A., van Tilburg M. Functional gastrointestinal disorders: child / adolescent. Gastroenterol 2016; 150: 1456—1468. DOI: org/10.1053/j.gastro.2016.02.015

3. Koppen I.J., Nurko S., Saps M., Di Lorenzo C, Bennin-ga M.A. The pediatric Rome IV criteria: what’s new? Expert Rev Gastroenterol Hepatol 2017; 11(3): 193—201. DOI: 10.1080/17474124.2017.1282820

4. Kovacic K., Miranda A., Chelimsky G., Williams S., Simpson P, Li B. Chronic idiopathic nausea of childhood. J Pediatr 2014; 164(5): 1104-1109. DOI: 10.1016/j.jpeds.2014.01.046

5. Saps M., Velasco-Benitez C.A., Langshaw A.H., Ramirez-Hernandez C.R. Prevalence of Functional Gastrointestinal Disorders in Children and Adolescents: Comparison Between Rome III and Rome IV Criteria. J Pediatr 2018; 199: 212-216. DOI: 10.1016/j.jpeds.2018.03.037

6. Singh P., Kuo B. Central Aspects of Nausea and \fomiting in GI Disorders. Curr Treat Options Gastroenterol 2016; 14(4): 444-451. DOI: 10.1007/s11938-016-0107-x

7. Trivic I., Hojsak I. Initial Diagnosis of Functional Gastrointestinal Disorders in Children Increases a Chance for Resolution of Symptoms. Pediatr Gastroenterol Hepatol Nutr 2018; 21(4): 264-270. DOI: 10.5223/pghn.2018.21.4.264

8. Canavan C., West J., Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol 2014; 6: 71-80. DOI: 10.2147/CLEP.S40245

9. Shcherbak V.A. The prevalence of Helicobacter pylori infection in children with the syndrome of dyspepsia in the Trans-Baikal Territory. J Pediatric Gastroenterol Nutrit 2017; 64(Suppl.1): 570.

10. Data from the Department of medical care and resort development of the Federal state University «Central research Institute of health organization and Informatization» of the Ministry of health, 2011. Electronic resource: http://mednet.ru/index.php (in Russ.)

11. Pechkurov D.V., Shcherbakov P.L., Kaganova T.I. Dyspepsia syndrome in children. Mocow, Medpraktika-M, 2007; 143. (in Russ.)

12. Pechkurov D.V., Allenova Yu.E., Tyazheva A.A. The content of interleukin-1 in gastric mucus in children with functional dyspepsia. Voprosy detskoi dietologii 2016; 14(2): 29-31. (in Russ.)

13. Drossman D.A., Hasler W.L. Rome IV - Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterol 2016; 150(6): 1257-1261. DOI: 10.1053/j.gastro.2016.03.035

14. Drossman D.A. The functional gastrointestinal disorders and the Rome III process. Gastroenterol 2006; 130: 1377-1390. DOI: 10.1053/j.gastro.2006.03.008

15. Chitkara D.K., Camilleri M., Zinsmeister A.R., Burton D., El-Youssef M., Freese D. et al. Gastricsensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr 2005; 146: 500-505. DOI: 10.1016/j.jpeds.2004.11.031

16. Feinle-Bisset C., Vozzo R., Horowitz M., Talley N. Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99: 170-181. DOI: 10.1111/j.1572-0241.2004.04003.x

17. Akamizu T., Iwakura H., Ariyasu H., Kangawa K. Ghrelin and functional dyspepsia. Int J Peptides 2010; 1: 1-6. DOI: 10.1155/2010/548457

18. Lazebnik L.B., Tkachenko E.I., Abdulganieva D.I., Abdulhakov R.A., Abdulhakov S.R., Avalueva E.B. et al. VI National recommendations for the diagnosis and treatment of acid-dependent and Helicobacter pylori-associated diseases (VI Moscow agreements). Eksperimental’naya i klinich-eskaya gastroenterologiya 2017; 2(138): 3-21. (in Russ.)

19. Jones N.L., Koletzko S., Goodman K., Bontems P., Cad-ranel S., Casswall T. et al. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr 2017; 64(6): 991-1003. DOI: 10.1097/MPG.0000000000001594

20. Nizhevich A.A., Valeeva D. S., Sataev V.U., Gafurova K.A., Ahmadeeva E.N., Ahmetshin R.Z. Modern approaches to the treatment of functional dyspepsia in childhood. Voprosy detskoi dietologii 2017; 15(3): 5-11. (in Russ.)

21. Browne P.D., Nagelkerke S.C.J., van Etten-Jamaludin F.S., Benninga M.A., Tabbers M.M. Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review. Expert Rev Clin Pharmacol 2018; 11(12): 1195-1208. DOI: 10.1080/17512433.2018.1540298

22. PRAC recommends restricting use of domperidone Benefits still considered to outweigh risks when given short-term and in low doses to treat nausea or vomiting 07 March 2014 EMA/129231/2014. The way of access: www.ema.europa.eu

23. Xiping Z., Hongpeng X. Cerekinon’s effect on esophageal dynamics in patients with endoscopy-negative gastroesophageal reflux disease through esophageal manometry. China Medical Equipment 2007; 8: 16-20.

24. Aktas A., Caner B., Ozturk F., Bayhan H., Narin Y., Mentes T. The effect of trimebutine maleate on gastric emptying in patients with non-ulcer dyspepsia. Ann Nucl Medicine 1999; 13(4): 231-234. DOI: 10.1007/BF03164897

25. Boige N., Cargill G., Mashako L., Cezard J.P., Navarro J. Trimebutine-induced phase III-like activity in infants with intestinal motility disorders. J Ped Gastroenterol Nutr 1987; 6(4): 548-553. DOI: 10.1097/00005176-198707000-00010

26. Kim B.J., Kuo B. Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment. J Neurogastroenterol Motil 2018; 25(1): 27-35. DOI: 10.5056/jnm18162

27. Keita A.V., Soderholm J.D. Mucosal permeability and mast cells as targets for functional gastrointestinal disorders. Curr Opin Pharmacol 2018; 43: 66-71. DOI: 10.1016/j.coph.2018.08.011

28. Mel’ce-va E.M., Kulik E.I., Oleksenko L.L., Dusaleeva T.M., Revenko N.A. Physical methods of treatment of function-al dyspepsia in children. Vestnik fizioterapii i kurortologii 2016; 22(4): 49-57. (in Russ.)

29. Kazyulin A.N., Dicheva D.T., Russ I.S., Andreev D.N., Parcvania-Vinogradova E.V. Diet therapy with reduced content of fermentable oligosaccharides, disaccharides, monosaccharides and polyols (fodmap) for irritable bowel syndrome. Consilium Medicum 2016; 18(8): 75-78. (in Russ.)

30. Maev I.V., Dicheva D.T., Andreev D.N., Senina Yu.S. Irritable bowel syndrome in the practice of a gastroenterologist. In: Topical issues of departmental medicine. Moscow, 2012; 83-88. (in Russ.)

31. Lovell R.M., Ford A.C. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721. DOI: 10.1016/j.cgh.2012.02.029

32. Pechkurov D.V., Allenova Yu.E., Tyazheva A.A. Age-related features of functional disorders of the gastrointestinal tract, manifested by abdominal pain, from the perspective of a biopsychosocial model. Voprosy detskoi dietologii 2015; 13(2): 11-15. (in Russ.)

33. Barbara G., Stanghellini V., De Giorgio R., Cremon C., Cottrell G.S., Santini D. et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterol 2004; 126: 693-702. DOI: 10.1053/j.gastro.2003.11.055

34. Ohman L., Simren M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7: 163-173. DOI: 10.1038/nr-gastro.2010.4

35. Johannesson E, Simren M., Strid H, Ringstrom G. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol 2011; 106: 915-922. DOI: 10.1038/ajg.2010.480

36. Nath A., Haktanirlar G., Varga A., Molnar M.A., Albert K., Galambos I. et al. Biological activities of Lactose-derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal system. Meditsina 2018; 54(2): 18. DOI: 10.3390/medici-na54020018

37. Chen C., Li L., Wu Z., Chen H., Fu S. Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis. J Infect 2007; 54(1): 98-102. DOI: 10.1016/j.jinf.2005.11.013

38. Sperber A.D., Drossman D.A. Review article: the functional abdominal pain syndrome. Aliment Pharmacol Ther 2011; 33: 514-524. DOI: 10.1111/j.1365-2036.2010.04561.x

39. Devanarayana N.M., Mettananda S., Liyanarachchi C., Nan-ayakkara N., Mendis N., Perera N., Rajindrajith S. Abdominal pain-predominant functional gastrointestinal diseases in children and adolescents: prevalence, symptomatology, and association with emotional stress. J Pediatr Gastroenterol Nutr 2011; 53: 659-665. DOI: 10.1097/MPG.0b013e3182296033

40. Clouse R.E., Mayer E.A., Aziz Q-, Drossman D.A., Dumitras-cu D.L., Monnikes El., Naliboff B.D. Functional abdominalpain syndrome. Gastroenterol 2006; 130: 1492—1497. DOI: 10.1053/j.gastro.2005.11.062

41. Yacob D., Di Lorenzo C., Bridge J.A., Rosenstein P.F., Onora-to M., Bravender T., Campo J.V. Prevalence of pain-predominant functional gastrointestinal disorders and somatic symptoms in patients with anxiety or depressive disorders. J Pediatr 2013; 163: 767-770. DOI: 10.1016/j.jpeds.2013.02.033

42. Drossman D.A. The physican-patient relationship. In: Approach to the patient with chronic gastrointestinal disorders. E. Corazziari (ed.). Milano, 2000; 133-139.

43. Saps M., Youssef N., Miranda A., Hyman P., Cocjin J., Di Lorenzo C. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterol 2009; 137: 1261-1269. DOI: 10.1053/j.gastro.2009.06.060

44. Levy R.L., Langer S.L., Walker L.S., Romano J.M., Christie D.L., Youssef N. et al. Cognitive behavioral therapy for children with functional abdominal pain and their parents decreases pain and other symptoms. Am J Gastroenterol 2010; 105: 946-956. DOI: 10.1038/ajg.2010.106